Title : Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus.

Pub. Date : 2013 Oct

PMID : 23522182






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus. AZD1656 glucokinase Homo sapiens
2 AIM: To assess the glucose-lowering effects of monotherapy with the glucokinase activator AZD1656 in Japanese patients with type 2 diabetes mellitus. AZD1656 glucokinase Homo sapiens